Kendall Law Group Investigating Javelin Pharmaceuticals, Inc. Merger Agreement
Kendall Law Group is investigating the merger of Javelin Pharmaceuticals, Inc. (AMEX: JAV) with Hospira, Inc. on behalf of Javelin shareholders. The national securities litigation firm is investigating whether a fair process was used by Javelin’s Board of Directors prior to entering into the merger agreement and whether they breached their fiduciary duties by not seeking a deal that would provide better value of the Company for shareholders. Javelin shareholders with questions or information on the firm’s investigation are encouraged to contact the Kendall Law Group at 877-744-3728 or by email at email@example.com.
On April 19, 2010, Javelin announced that it had entered into an agreement to be acquired by Hospira in an all cash transaction valued at approximately $145 million. According to the agreement, shareholders will receive $2.20 per JAV share owned, just pennies over the closing price the past few days. Javelin stock has also closed at $2.12 on July 29, 2009 and $2.04 on September 22, 2009. The transaction is expected to move quickly, commencing within five business days and staying open for twenty.
Kendall Law Group, founded by a former federal judge, includes a former
United States Attorney, prosecutors and securities lawyers who are
experienced in complex securities litigation. The firm has been counsel
in many merger and acquisition cases nationwide, including some of the
largest transactions in the United States.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV